A Phase II/III Randomized Trial of VELIPARIB or PLACEBO in combination with  adjuvant TEMOZOLOMIDE in newly diagnosed Glioblastoma with MGMT promoter Hypermethyation.

 

Coordinator’s Contact Info:

Tresalynn
786-296-9310
MSMC ONLY